Abstract
Adverse event could be present for all treatments for autoimmune conditions.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
Rights and permissions
About this article
Cite this article
Sheridan, C. Tysabri risk causing headache for companies. Nat Rev Drug Discov 4, 703–704 (2005). https://doi.org/10.1038/nrd1837
Issue date:
DOI: https://doi.org/10.1038/nrd1837
